BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Vivo Bio Tech Ltd. Share Price

NSE
BSE

BSE : 511509

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹20.25
Day's Range ₹20.00 - ₹21.16
Open ₹21.16
52 Week Range ₹18.36 - ₹43.35
Volume 35,909
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 7.27
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -1.29
P/E Ratio 8.01
Book Value(₹) 0.51
PAT Margin (%) 15.60
Face Value (₹) 10.00
ROCE(%) 12.63

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 125.12 466.72
Expenses N/A N/A
PBT 14.79 87.93
Operating profit 0.0 0.0
Net profit 13.37 72.83

Shareholding Pattern

Promoters (% Holding)

30.62%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

69.38%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Vivo Bio Tech Ltd.

Founded 1987

Latest News

Jul
15
2026
EQUITY Posted on Jul 15th 2026

Vivo Bio Tech informs about press release

Vivo Bio Tech has informed that it enclosed the copies of advertisement issued in newspapers on July 15, 2026, in ‘Financial Express’ in English Language and in ‘Nava Telangana’ in Telugu Language, with respect to the Un-Audited Financial Results of the Company for the First Quarter ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
14
2026
EQUITY Posted on Jul 14th 2026

Vivo Bio Tech informs about unaudited financial results

Vivo Bio Tech has informed that the Board of Directors of the Company at their meeting held on Monday, July 13, 2026, transacted the following business: Considered and approved the Unaudited Standalone & Consolidated Financial Results of the Company for the First quarter ended June 30, 2026. A copy of the signed Results along with Limited Review Report issued by the Statutory Auditors, P. Murali & Co., Chartered Accountants, are enclosed as Annexure-A. The meeting commenced at 07:00 pm and concluded at 07:30 pm.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
25
2026
EQUITY Posted on Jun 25th 2026

Vivo Bio Tech informs about closure of trading window

Vivo Bio Tech has informed that, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from July 01, 2026 till the end of 48 hours after the declaration of the Unaudited Standalone and Consolidates Financial Results of the Company for the First quarter ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
12
2026
EQUITY Posted on Jun 12th 2026

Vivo Bio Tech informs about notice of postal ballot

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vivo Bio Tech has informed that it enclosed the Notice of Postal Ballot & E -Voting, together with the Explanatory Statement thereto, seeking approval of the Members for the Special Business as set out in the said Notice.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
2
2026
EQUITY Posted on Jun 2nd 2026

Vivo Bio Tech informs about press release

Vivo Bio Tech has informed that it enclosed the copies of advertisement issued in newspapers on June 02, 2026, in ‘Financial Express’ in English Language and in ‘Nava Telangana’ in Telugu Language, with respect to the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Vivo Bio Tech Ltd. ?

The current share price of Vivo Bio Tech Ltd. is ₹20.25 as of 2026-08-13.

The market capitalisation of Vivo Bio Tech Ltd. is ₹46.49 as of 2026-08-12.

The 1-year return of Vivo Bio Tech Ltd. is -15.30% as of 2025-08-12.

The P/E ratio of Vivo Bio Tech Ltd. is 8.01 as of 2026-08-13.

The 52-week high and low of Vivo Bio Tech Ltd. are ₹43.35 and ₹18.36, respectively, as of 2026-08-13.

The dividend yield of Vivo Bio Tech Ltd. is 0.0% as of2026-08-12.

You can buy Vivo Bio Tech Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Vivo Bio Tech Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore